申请人:Merck Sharp & Dohme Corp.
公开号:US20170340610A1
公开(公告)日:2017-11-30
The present invention relates to compounds according to Formula (I) or a pharmaceutically acceptable salt or solvate thereof. Such compounds can be used in the treatment of RORgammaT-mediated diseases or condition.